Omega 3 /01334101/


Combined with:

Enbrel

Indications and Reactions:

Role Indications Reactions
Secondary
Product Used For Unknown Indication 95.7%
Type 2 Diabetes Mellitus 4.3%
Death 50.0%
Diarrhoea 50.0%
Concomitant
Product Used For Unknown Indication 54.9%
Rheumatoid Arthritis 9.9%
Hypertension 5.0%
Hepatitis C 3.4%
Diabetes Mellitus 3.0%
Prophylaxis 2.8%
Psoriatic Arthropathy 2.5%
Vitamin Supplementation 2.3%
Osteoporosis Postmenopausal 1.9%
Type 2 Diabetes Mellitus 1.9%
Osteoporosis 1.8%
Psoriasis 1.8%
Pain 1.4%
Arthritis 1.2%
Depression 1.2%
Supplementation Therapy 1.2%
Blood Pressure 1.1%
Dyslipidaemia 1.1%
Type 1 Diabetes Mellitus 0.9%
Back Pain 0.7%
Drug Ineffective 14.1%
Nasopharyngitis 9.1%
Therapeutic Response Decreased 8.1%
Injection Site Pain 7.1%
Psoriasis 7.1%
Injection Site Swelling 5.1%
Fatigue 4.0%
Pain 4.0%
Paraesthesia 4.0%
Rash 4.0%
Sinusitis 4.0%
Vomiting 4.0%
Weight Decreased 4.0%
Angina Unstable 3.0%
Injection Site Bruising 3.0%
Liver Function Test Abnormal 3.0%
Nausea 3.0%
Pain In Extremity 3.0%
Pyrexia 3.0%
Weight Increased 3.0%

Drug Data